Skip to main content
. 2021 Dec 1;13(23):6067. doi: 10.3390/cancers13236067

Figure 1.

Figure 1

Overview of cancer immunotherapy approaches: ADCC: antibody-dependent cellular cytotoxicity; BiTE: bispecific T cell engager; mAbs: monoclonal antibodies; TILs: tumor-infiltrating lymphocytes; HSV-1: Herpes simplex virus-1.